RP-101075 is an active metabolite of Ozanimod and functions as a potent oral S1PR1 agonist (EC50 = 0.27 nM); it exhibits >100-fold selectivity over S1PR5 (EC50 = 5.9 nM) and >10,000-fold selectivity over S1PR2, S1PR3, and S1PR4; it demonstrates superior cardiovascular safety.